Status:
TERMINATED
Digital Cognitive Remote Training in Alzheimer's Disease (MA-EIAD)
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Alzheimer Disease
Eligibility:
All Genders
60+ years
Phase:
NA
Brief Summary
Cerebral functioning changes with age in order to respond to the impacts of different external and internal factors on the brain, and more generally on the human body. Scaffolding Theory of Aging and ...
Eligibility Criteria
Inclusion
- 60 years old or more
- native French speaker
- Diagnosis of Alzheimer's disease according DMS-V criteria
- early to moderate stage of the disease (MMSE \> 15)
- psychotropic drug treatment without change for three months at least
- signed informed consent
- being affiliated to a social security
Exclusion
- not corrected visual or auditory deficit
- motor deficits preventing experimental tests execution
- ongoing participation in cognitive training or stimulation for more than three months
- not having a computer at the place of residence
- refusal of participation
- being under guardianship
Key Trial Info
Start Date :
October 28 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 25 2022
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT04010175
Start Date
October 28 2019
End Date
January 25 2022
Last Update
March 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de Neuropsychologie - Hôpital Neurologique, Hospices Civils de Lyon
Bron, France, 69677